[Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor)].

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Medizinische Klinik

• Publication date

  1994-11-15

• Fields of study

  Medicine

• Identifiers
  PMID 7815986
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Subacute 28-Day OECD-Guided Oral Toxicity Study of Escherichia coli 5C (LMG S-33222) in Wistar Rats and Immunocompromised Nude Mice

  2026cites this paper
• Neutrophil recruitment during intestinal inflammation primes Salmonella elimination by commensal E. coli in a context-dependent manner.

  2025cites this paper
• Bioengineered gut bacterium synthesizing levodopa alleviates motor deficits in models of Parkinson's disease.

  2025cites this paper
• Correlation of the intestinal flora and its metabolites with the colonic transport function in functional constipation

  2025cites this paper
• Construction and characterization of a hypervesiculation strain of Escherichia coli Nissle 1917

  2024cites this paper
• The Effect of Probiotic Supplementation on the Gut–Brain Axis in Psychiatric Patients

  2023cites this paper
• Engineered bacteria producing aryl-hydrocarbon receptor agonists protect against ethanol-induced liver disease in mice.

  2023cites this paper
• Deletion of the cheZ gene results in the loss of swimming ability and the decrease of adhesion ability to Caco-2 cells in Escherichia coli Nissle 1917

  2022cites this paper
• Aktualisierte S2k-Leitlinie chronische Obstipation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie & Motilität (DGNM) – April 2022 – AWMF-Registriernummer: 021–019

  2022cites this paper
• Probiotics and synbiotics in chronic constipation in adults: A systematic review and meta-analysis of randomized controlled trials.

  2022cites this paper
• Anti-rotavirus Properties and Mechanisms of Selected Gram-Positive and Gram-Negative Probiotics on Polarized Human Colonic (HT-29) Cells

  2022cites this paper
• Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (D

  2022cites this paper
• Design and Implementation of the Modern Men’s Health Center: A Multidisciplinary Approach

  2021cites this paper
• Microbiome and gastrointestinal malignancies

  2021cites this paper
• The e cacy of Bi dobacterium bi dum G9-1 in improving quality of life in patients with chronic constipation

  2021cites this paper
• Siderophore-mediated zinc acquisition enhances enterobacterial colonization of the inflamed gut

  2021cites this paper
• Efficacy of Bifidobacterium bifidum G9-1 in improving quality of life in patients with chronic constipation: a prospective intervention study

  2021cites this paper
• The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: a systematic review and meta-analysis based on seventeen randomized controlled trials.

  2020cites this paper
• Siderophore-mediated zinc acquisition enhances enterobacterial colonization of the inflamed gut

  2020cites this paper
• The efficacy of Bifidobacterium bifidum G9-1 in improving quality of life in patients with chronic constipation

  2020cites this paper
• Probiotics

  2020cites this paper
• Current status of probiotics for prevention and management of gastrointestinal cancers

  2020cites this paper
• Probiotics for Management of Gastrointestinal Cancers

  2020cites this paper
• Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917

  2019cites this paper
• Enumeration of Escherichia coli in Probiotic Products

  2019cites this paper
• Systematic review of randomised controlled trials

  2018cites this paper
• Rebuilding the Gut Microbiota Ecosystem

  2018cites this paper
• Probiotics and their role in gastrointestinal cancers prevention and treatment; an overview

  2018cites this paper
• An adherent mucus layer attenuates the genotoxic effect of colibactin

  2018cites this paper
• Randomised clinical trial: Bifidobacterium lactis NCC2818 probiotic vs placebo, and impact on gut transit time, symptoms, and gut microbiology in chronic constipation

  2018cites this paper
• Escherichia coli Nissle 1917

  2017cites this paper
• Chapter 1 – Regulatory Considerations for the Use and Marketing of Probiotics and Functional Foods

  2016cites this paper
• Insights from 100 Years of Research with Probiotic E. Coli

  2016cites this paper
• Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.

  2016cites this paper
• Reviewing clinical studies of probiotics as dietary supplements: probiotics for gastrointestinal disorders, Helicobacter eradication, lactose malabsorption and inflammatory bowel disease (IBD)

  2015cites this paper
• Effects of a kefir supplement on symptoms, colonic transit, and bowel satisfaction score in patients with chronic constipation: a pilot study.

  2015influential citation
• Review on microbiota and effectiveness of probiotics use in older.

  2015cites this paper
• Interplay between enterobactin, myeloperoxidase and lipocalin 2 regulates E. coli survival in the inflamed gut

  2015cites this paper
• Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance

  2015cites this paper
• The probiotic Escherichia coli Nissle 1917 inhibits propagating colonic contractions in the rat isolated large intestine.

  2015cites this paper
• Production of functional food, Fruit ravioli with antihypertensive peptides

  2014cites this paper
• Metabolism in chronic fatigue syndrome.

  2014cites this paper
• Production of functional food , Fruit ravioli with antihypertensive peptides

  2014cites this paper
• The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials.

  2014cites this paper
• Efeito do simbiótico no funcionamento gastrointestinal e perfil lipídico de idosos institucionalizados: um estudo randomizado, duplo cego controlado por placebo

  2014cites this paper
• Obstipação Crónica em Adultos, do Diagnóstico ao tratamento

  2013cites this paper
• Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron.

  2013cites this paper
• The Role of Probiotics and Prebiotics in Inducing Gut Immunity

  2013cites this paper
• S2k-Leitlinie Chronische Obstipation: Definition, Pathophysio- logie, Diagnostik und Therapie Gemeinsame Leitlinie der Deutschen Gesellschaft für Neurogastro- enterologie und Motilität (DGNM) und der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) 1 - AWMF-Registriernummer:

  2013cites this paper
• S2k-Leitlinie Chronische Obstipation: Definition, Pathophysiologie, Diagnostik und Therapie Gemeinsame Leitlinie der Deutschen Gesellschaft für Neurogastroenterologie und und der Gesellschaft und 1

  2013cites this paper
• S2k-Leitlinie Chronische Obstipation: Definition, Pathophysiologie, Diagnostik und Therapie Gemeinsame Leitlinie der Deutschen Gesellschaft für Neurogastroenterologie und und der Gesellschaft und 1

  2013cites this paper
• Effect of synbiotic in constipated adult women - a randomized, double-blind, placebo-controlled study of clinical response.

  2013cites this paper
• Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.

  2013cites this paper
• Probiotics: properties, examples, and specific applications.

  2013cites this paper
• Chronische Obstipation

  2013cites this paper
• Topic 12 消化器疾患の栄養管理

  2013cites this paper
• S2k-Leitlinie Chronische Obstipation: Definition, Pathophysiologie, Diagnostik und Therapie Gemeinsame Leitlinie der Deutschen Gesellschaft für Neurogastroenterologie und und der Gesellschaft und 1

  2013cites this paper
• Probiotika bei Reizdarmsyndrom

  2012cites this paper
• Chronic Constipation in the Elderly

  2012cites this paper
• Intestinale Motilitätsstörungen

  2012cites this paper
• More than a marine propeller--the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus.

  2012cites this paper
• Gastrointestinal Microbiota and Some Children Diseases: A Review

  2012cites this paper
• A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome

  2011cites this paper
• S3-Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) zu Definition, Pathophysiologie, Diagnostik und Therapie intestinaler Motilitätsstörungen1

  2011cites this paper
• Synbiotic preparation in men suffering from functional constipation: a randomised controlled trial.

  2011cites this paper
• S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)1

  2011cites this paper
• ) 1 AWMF-Registriernummer : 021 / 016 Irritable Bowel Syndrome : German Consensus Guidelines on Definition , Pathophysiology and Management

  2011cites this paper
• Clinical Nutrition University: Nutrition in the prevention and management of irritable bowel syndrome, constipation and diverticulosis

  2011cites this paper
• Guías de diagnóstico y tratamiento del estreñimiento en México. C) Tratamiento médico y quirúrgico

  2011cites this paper
• WHAT ARE THE COMMON FACTORS THAT CONTRIBUTE TO CONSTIPATION IN THE ELDERLY ?

  2011cites this paper
• [Recommendations on therapy for chronic constipation--working group for functional diagnosis and psychosomatics of the austrian society of gastroenterology and hepatology].

  2011cites this paper
• S3-Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechsel- krankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastro- enterologie und Motilität (DGNM) zu Definition, Pathophysiologie, Diagnostik und Therapie intestinaler Motilitätsstörungen 1 AWMF-Registriernummer: 021/018

  2011cites this paper
• [Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management].

  2011cites this paper
• Safety of Probiotics to Reduce Risk and Prevent or Treat Disease

  2011cites this paper
• Empfehlungen zur Therapie der chronischen Obstipation der Arbeitsgruppe für Funktionsdiagnostik und Psychosomatik der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie

  2011cites this paper
• S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)1

  2011cites this paper
• Chronic constipation: current treatment options.

  2011cites this paper
• Effect of Lactobacillus casei Shirota on colonic transit time in patients with chronic constipation

  2011cites this paper
• The K5 Capsule of Escherichia coli Strain Nissle 1917 Is Important in Stimulating Expression of Toll-Like Receptor 5, CD14, MyD88, and TRIF Together with the Induction of Interleukin-8 Expression via the Mitogen-Activated Protein Kinase Pathway in Epithelial Cells

  2010cites this paper
• Therapieoptionen bei Obstipation und Diarrhö

  2010cites this paper
• Systematic review of randomised controlled trials: probiotics for functional constipation.

  2010cites this paper
• Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study.

  2010cites this paper
• Aspects of Nutritional Counselling for disorders of gastrointestinal microbiota in individuals with genetic and molecular dispositions

  2010cites this paper
• Nutritional Support in Gastrointestinal Disease Topic 12 Module 12 . 6 Nutritional in prevention and management of irritable bowel syndrome , constipation and diverticulosis

  2009cites this paper
• Nutritional Support in Gastrointestinal Disease

  2009cites this paper
• The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic

  2009cites this paper
• Cell‐free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study

  2009cites this paper
• The K5 Capsule of Escherichia coli Strain Nissle 1917 Is Important in Mediating Interactions with Intestinal Epithelial Cells and Chemokine Induction

  2009cites this paper
• Influence of E. coli Strain Nissle 1917 (EcN) on Intestinal Gas Dynamics and Abdominal Sensation

  2008cites this paper
• Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women.

  2008cites this paper
• Probiotics, prebiotics, and synbiotics.

  2008cites this paper
• Signaltransduktion und Signalverarbeitung desprobiotischen Bakteriums E. coli Nissle 1917 in vitro

  2008cites this paper
• Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO‐2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair

  2007cites this paper
• [Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].

  2007cites this paper
• Integrative approaches to childhood constipation and encopresis.

  2007cites this paper
• Prebiotics and Probiotics in Infant Nutrition

  2007cites this paper
• Probiotics and prebiotics — renaissance of a therapeutic principle

  2007cites this paper
• Beeinflussung der Apoptoserate und Zellzyklusprogression humaner T-Zellen durch den probiotischen E. coli Stamm Nissle 1917

  2006cites this paper
• [Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3,807 patients].

  2006cites this paper
• Probiotics in Gastrointestinal Diseases in Children: Hard and Not-So-Hard Evidence of Efficacy

  2006cites this paper